96 related articles for article (PubMed ID: 15623482)
1. The characteristics of human papillomavirus DNA in head and neck cancers and papillomas.
Major T; Szarka K; Sziklai I; Gergely L; Czeglédy J
J Clin Pathol; 2005 Jan; 58(1):51-5. PubMed ID: 15623482
[TBL] [Abstract][Full Text] [Related]
2. Mucosal and cutaneous human papillomaviruses in head and neck squamous cell papillomas.
Donà MG; Pichi B; Rollo F; Gheit T; Laquintana V; Covello R; Pescarmona E; Spriano G; Pellini R; Giuliani M; Tommasino M; Benevolo M
Head Neck; 2017 Feb; 39(2):254-259. PubMed ID: 27618734
[TBL] [Abstract][Full Text] [Related]
3. Methylation of CpG sites in the upstream regulatory region, physical status and mRNA expression of HPV-6 in adult-onset laryngeal papilloma.
Deng Z; Ikegami T; Kiyuna A; Zhang C; Zhang T; Matayoshi S; Uehara T; Maeda H; Suzuki M; Ganaha A
Oncotarget; 2017 Oct; 8(49):85368-85377. PubMed ID: 29156725
[TBL] [Abstract][Full Text] [Related]
4. Human Papillomavirus Type 16 Integration Analysis by Real-time PCR Assay in Associated Cancers.
Karbalaie Niya MH; Keyvani H; Safarnezhad Tameshkel F; Salehi-Vaziri M; Teaghinezhad-S S; Bokharaei Salim F; Monavari SHR; Javanmard D
Transl Oncol; 2018 Jun; 11(3):593-598. PubMed ID: 29547758
[TBL] [Abstract][Full Text] [Related]
5. Navigating therapeutic strategies: HPV classification in head and neck cancer.
Tabatabaeian H; Bai Y; Huang R; Chaurasia A; Darido C
Br J Cancer; 2024 Apr; ():. PubMed ID: 38643337
[TBL] [Abstract][Full Text] [Related]
6. Correction to "A risk prediction model for head and neck cancers incorporating lifestyle factors, HPV serology and genetic markers".
Int J Cancer; 2024 Feb; 154(3):E3. PubMed ID: 37982348
[No Abstract] [Full Text] [Related]
7. HPV-Associated Benign Squamous Cell Papillomas in the Upper Aero-Digestive Tract and Their Malignant Potential.
Syrjänen S; Syrjänen K
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452488
[TBL] [Abstract][Full Text] [Related]
8. How Enhancing Immunity to Low-Risk HPV Could Cure Recurrent Respiratory Papillomatosis.
Bai K; Allen C
Laryngoscope; 2021 Sep; 131(9):2041-2047. PubMed ID: 33720393
[TBL] [Abstract][Full Text] [Related]
9. Immunological tolerance of low-risk HPV in recurrent respiratory papillomatosis.
Ivancic R; Iqbal H; deSilva B; Pan Q; Matrka L
Clin Exp Immunol; 2020 Feb; 199(2):131-142. PubMed ID: 31628850
[TBL] [Abstract][Full Text] [Related]
10. Experimental research on the therapeutic effect of MMR vaccine to juvenile-onset recurrent respiratory papillomatosis.
Wang Y; Dai PD; Zhang TY
Eur Arch Otorhinolaryngol; 2019 Mar; 276(3):801-803. PubMed ID: 30806807
[TBL] [Abstract][Full Text] [Related]
11. MVA E2 therapeutic vaccine for marked reduction in likelihood of recurrence of respiratory papillomatosis.
Cabo Beltran OR; Rosales Ledezma R
Head Neck; 2019 Mar; 41(3):657-665. PubMed ID: 30605254
[TBL] [Abstract][Full Text] [Related]
12. HPV vaccination as preventive approach for recurrent respiratory papillomatosis - a 22-year retrospective clinical analysis.
Mauz PS; Schäfer FA; Iftner T; Gonser P
BMC Infect Dis; 2018 Jul; 18(1):343. PubMed ID: 30041619
[TBL] [Abstract][Full Text] [Related]
13. Oral and oropharyngeal papillomas are not associated with high-risk human papillomavirus infection.
Snietura M; Lamch R; Kopec A; Waniczek D; Likus W; Lange D; Markowski J
Eur Arch Otorhinolaryngol; 2017 Sep; 274(9):3477-3483. PubMed ID: 28639061
[TBL] [Abstract][Full Text] [Related]
14. Detection of High-Risk Human Papillomavirus Genotypes 16 and 18 in Head and Neck Squamous Cell Carcinomas in Jordan.
Abu Qatouseh L; Sabri I; Alkhatib I; Atwa E; Arafat T
Asian Pac J Cancer Prev; 2017 May; 18(5):1337-1341. PubMed ID: 28612284
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of HPV Infection in Racial-Ethnic Subgroups of Head and Neck Cancer Patients.
Ragin C; Liu JC; Jones G; Shoyele O; Sowunmi B; Kennett R; Groen HJ; Gibbs D; Blackman E; Esan M; Brandwein MS; Devarajan K; Bussu F; Chernock R; Chien CY; Cohen MA; Samir EM; Mikio S; D'Souza G; Funchain P; Eng C; Gollin SM; Hong A; Jung YS; Krüger M; Lewis J; Morbini P; Landolfo S; Rittà M; Straetmans J; Szarka K; Tachezy R; Worden FP; Nelson D; Gathere S; Taioli E
Carcinogenesis; 2017 Feb; 38(2):218-229. PubMed ID: 28025390
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus and lung cancinogenesis: an overview.
de Freitas AC; Gurgel AP; de Lima EG; de França São Marcos B; do Amaral CM
J Cancer Res Clin Oncol; 2016 Dec; 142(12):2415-2427. PubMed ID: 27357515
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical Study EMT-Related Proteins in HPV-, and EBV-Negative Patients with Sinonasal Tumours.
Stasikowska-Kanicka O; Wągrowska-Danilewicz M; Danilewicz M
Pathol Oncol Res; 2016 Oct; 22(4):781-8. PubMed ID: 27138192
[TBL] [Abstract][Full Text] [Related]
18. Verrucous carcinoma and squamous cell papilloma of the oral cavity: Report of two cases and review of literature.
Alan H; Agacayak S; Kavak G; Ozcan A
Eur J Dent; 2015; 9(3):453-456. PubMed ID: 26430380
[TBL] [Abstract][Full Text] [Related]
19. A role for microRNA-155 expression in microenvironment associated to HPV-induced carcinogenesis in K14-HPV16 transgenic mice.
Paiva I; Gil da Costa RM; Ribeiro J; Sousa H; Bastos M; Faustino-Rocha A; Lopes C; Oliveira PA; Medeiros R
PLoS One; 2015; 10(1):e0116868. PubMed ID: 25625305
[TBL] [Abstract][Full Text] [Related]
20. Squamous papilloma of the hard palate.
Babaji P; Singh V; Chaurasia VR; Masamatti VS; Sharma AM
Indian J Dent; 2014 Oct; 5(4):211-3. PubMed ID: 25565755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
